Delivery Order SPE2DB22D3301-SPE2DB24FZ4AX
Award Date
9/4/24
Potential Completion Date
9/5/24
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,294.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,926,728 units of Tamsulosin HCL 0.4 mg capsules, with a performance period ending on April 16, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,796.09, is for the delivery of 4,566,770,572 units of the drug Tamsulosin HCl 0.4 mg capsules. The contract is a Firm Fixed Price Delivery Order with a completion date of December 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at...
This federal contract award, valued at $1,423.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,566,178,585 units of Tamsulosin HCl 0.4 mg capsules and has an ultimate completion date of October 23, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,781,311 units of the generic drug Tamsulosin HCL 0.4 mg capsules. The fixed-price contract is valued at $7,707.57 and has an ultimate completion date of April 3, 2025. The award is not associated with a set-aside program. This contract is part of a larger $999,999,999 Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,352,432 units of Tamsulosin Hydrochloride 0.4 mg capsules. The contract has a ceiling value of $2,486.38 and a completion date of November 7, 2024. The award is not associated with a set-aside program. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,561,823,091 units of Tamsulosin HCL 0.4 mg capsules. The contract has a firm fixed price of $5,949.44 and an ultimate completion date of August 16, 2023. The contract was awarded on August 15, 2023 and was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor...
This $2,888.08 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 4,565,910 units of the prescription drug Tamsulosin HCl 0.4 mg capsules. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, which enables the federal government to efficiently procure a wide range of essential pharmaceutical and medical...
This federal contract award, valued at $1,897.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,758,933 units of Tamsulosin HCL 0.4 mg capsules, a medication used for the treatment of benign prostatic hyperplasia. The contract is a Firm Fixed Price Delivery Order, with a period of performance through December 19, 2024. No set-aside designation was...
This is a $4,194.81 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 1,000 units of the drug Tamsulosin HCL 0.4 mg capsules. The contract has an ultimate completion date of March 31, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical division,...
This federal contract award, valued at $1,099.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,565,214,560 units of the medication Tamsulosin HCl 0.4 mg Capsules in 1,000-count bottles. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of July 22, 2024. There was no set-aside designation used for this...